© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Has the rise in the incidence of renal replacement therapy in developed countries come to an end?
ERA-EDTA Registry, Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands
Correspondence and offprint requests to: Kitty J. Jager, MD PhD, Professor of Medicine, UBC ERA-EDTA Registry, Academic Medical Center, Department of Medical Informatics, J1b 115.1 PO Box 22700, 1100 DE Amsterdam, The Netherlands. Email: k.j.jager@amc.uva.nl
Keywords: dialysis; incidence; renal replacement therapy; trend
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
In their 2006 annual data report, the USRDS reported that after years of considerable growth, the rate of new patients taken into renal replacement therapy (RRT) has begun to decrease slightly. Between 2002 and 2004, the overall incidence rate adjusted for age and sex declined by 1.1% to reach 339 per million population (pmp). This decline included a reduction in the incidence rate of RRT for diabetic ESRD of 2.1% to 149 pmp, over the same period. While the incidence rate in the white population had not changed since 2002, there was a decrease in the black, Native American and Asian patients of 4.0%, 5.5% and 8%, respectively [1]. However, subgroup analysis showed that the US incidence rates had decreased in females, but not in males. Furthermore, the continuing rise in diabetic ESRD rates for black patients, aged 30–39 years remained a cause for concern. Nevertheless, the data
|
Europe |
|---|
|
Other registries |
|---|
|
Factors affecting the incidence of RRT |
|---|
|
Conclusion |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in NDT:
- Is there really good news about pandemic diabetic nephropathy?
- Eli A. Friedman and Amy L. Friedman
NDT 2007 22: 681-683.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  A. Kramer, V. Stel, C. Zoccali, J. Heaf, D. Ansell, C. Gronhagen-Riska, T. Leivestad, K. Simpson, R. Palsson, M. Postorino, et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006 Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3557 - 3566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zoccali, A. Kramer, and K. J. Jager Chronic kidney disease and end-stage renal disease--a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe' NDT Plus, October 12, 2009; (2009) sfp127v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Covic, P. Gusbeth-Tatomir, and D. Goldsmith Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 56 - 61. [Full Text] [PDF]
|
|